{"id":{"repo_id":"athens","oai_identifier":"oai:lib.uoa.gr:uoadl:1314817"},"canonical_url":"https://search.ndltd.org/etd/athens/oai:lib.uoa.gr:uoadl:1314817","repository":{"repo_id":"athens","name":"National and Kapodistrian University of Athens","base_url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh"},"display":{"title":"Experimental design for the isolation of the possible receptor of the peptide Ec of the IGF-1Ec isoform with an affinity purification assay","abstract":"IGF-I is a key protein that regulates several biological functions. The Igf-1 gene mRNA undergoes several splicing and posttranslational modifications and gives rise to various isoforms, namely IGF-IEa, IGF-IEb and IGF-IEc in humans. These transcripts can produce the same bioactive product (mature IGF-I), however, they differ by the length of the amino-terminal (signal) peptide and the structure of the extension peptide (E-peptide) on their carboxy-terminal end. The IGF-I actions are mediated via its binding to the type I IGF receptor (IGF-IR), insulin receptor (IR) and hybrid IGF-I/IR receptors. There is an increasing interest in the possible different role of the IGF-I transcripts and their respective non-IGF-I products with distinct biological activities. Moreover, there is strong evidence of a differential expression profile of the IGF-I splice variants in several conditions and pathologies, implying that IGF-I transcription pattern and the respective products may possess different functions. Inparticular, IGF-IEc was found to be involved in several conditions and pathologies, such as skeletal and cardiac muscle damage and regeneration, endometriosis, osteosarcoma, prostate cancer, etc. The role of IGF-IEc isoform in the aforementioned conditions still eludes our grasp, nevertheless there is evidence that the Ec peptide of this IGF-I isoform may act via an IGF-I receptor (IGF-IR)- independent and insulin receptor (IR)-independent pathway, thus potentially via an, as yet, unknown receptor molecule. Herein, we describe the experimental design for the isolation of the possible receptor of the Ec peptide of the IGF-IEc isoform with the use of an affinity purification assay.","abstract_html":"IGF-I is a key protein that regulates several biological functions. The Igf-1 gene mRNA undergoes several splicing and posttranslational modifications and gives rise to various isoforms, namely IGF-IEa, IGF-IEb and IGF-IEc in humans. These transcripts can produce the same bioactive product (mature IGF-I), however, they differ by the length of the amino-terminal (signal) peptide and the structure of the extension peptide (E-peptide) on their carboxy-terminal end. The IGF-I actions are mediated via its binding to the type I IGF receptor (IGF-IR), insulin receptor (IR) and hybrid IGF-I/IR receptors. There is an increasing interest in the possible different role of the IGF-I transcripts and their respective non-IGF-I products with distinct biological activities. Moreover, there is strong evidence of a differential expression profile of the IGF-I splice variants in several conditions and pathologies, implying that IGF-I transcription pattern and the respective products may possess different functions. Inparticular, IGF-IEc was found to be involved in several conditions and pathologies, such as skeletal and cardiac muscle damage and regeneration, endometriosis, osteosarcoma, prostate cancer, etc. The role of IGF-IEc isoform in the aforementioned conditions still eludes our grasp, nevertheless there is evidence that the Ec peptide of this IGF-I isoform may act via an IGF-I receptor (IGF-IR)- independent and insulin receptor (IR)-independent pathway, thus potentially via an, as yet, unknown receptor molecule. Herein, we describe the experimental design for the isolation of the possible receptor of the Ec peptide of the IGF-IEc isoform with the use of an affinity purification assay.","abstract_has_math":false,"creators":["Θεοδωράκου Κωνσταντίνα"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-11-19T05:23:55Z","subjects":[],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:1314817"],"render_values":[{"text":"uoadl:1314817","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/1314817","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://pergamos.lib.uoa.gr/uoa/dl/object/1314817","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://pergamos.lib.uoa.gr/uoa/dl/frontend/oaipmh?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Alib.uoa.gr%3Auoadl%3A1314817","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Θεοδωράκου Κωνσταντίνα"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013"]},{"key":"dc:type","label":"Dc Type","values":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["uoadl:1314817","https://pergamos.lib.uoa.gr/uoa/dl/object/1314817"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["IGF-I is a key protein that regulates several biological functions. The Igf-1 gene mRNA undergoes several splicing and posttranslational modifications and gives rise to various isoforms, namely IGF-IEa, IGF-IEb and IGF-IEc in humans. These transcripts can produce the same bioactive product (mature IGF-I), however, they differ by the length of the amino-terminal (signal) peptide and the structure of the extension peptide (E-peptide) on their carboxy-terminal end. The IGF-I actions are mediated via its binding to the type I IGF receptor (IGF-IR), insulin receptor (IR) and hybrid IGF-I/IR receptors. There is an increasing interest in the possible different role of the IGF-I transcripts and their respective non-IGF-I products with distinct biological activities. Moreover, there is strong evidence of a differential expression profile of the IGF-I splice variants in several conditions and pathologies, implying that IGF-I transcription pattern and the respective products may possess different functions. Inparticular, IGF-IEc was found to be involved in several conditions and pathologies, such as skeletal and cardiac muscle damage and regeneration, endometriosis, osteosarcoma, prostate cancer, etc. The role of IGF-IEc isoform in the aforementioned conditions still eludes our grasp, nevertheless there is evidence that the Ec peptide of this IGF-I isoform may act via an IGF-I receptor (IGF-IR)- independent and insulin receptor (IR)-independent pathway, thus potentially via an, as yet, unknown receptor molecule. Herein, we describe the experimental design for the isolation of the possible receptor of the Ec peptide of the IGF-IEc isoform with the use of an affinity purification assay."]},{"key":"dc:title","label":"Title","values":["Experimental design for the isolation of the possible receptor of the peptide Ec of the IGF-1Ec isoform with an affinity purification assay"]}]}],"canonical_facts":{"dc:creator":["Θεοδωράκου Κωνσταντίνα"],"dc:date":["2013"],"dc:description":["IGF-I is a key protein that regulates several biological functions. The Igf-1 gene mRNA undergoes several splicing and posttranslational modifications and gives rise to various isoforms, namely IGF-IEa, IGF-IEb and IGF-IEc in humans. These transcripts can produce the same bioactive product (mature IGF-I), however, they differ by the length of the amino-terminal (signal) peptide and the structure of the extension peptide (E-peptide) on their carboxy-terminal end. The IGF-I actions are mediated via its binding to the type I IGF receptor (IGF-IR), insulin receptor (IR) and hybrid IGF-I/IR receptors. There is an increasing interest in the possible different role of the IGF-I transcripts and their respective non-IGF-I products with distinct biological activities. Moreover, there is strong evidence of a differential expression profile of the IGF-I splice variants in several conditions and pathologies, implying that IGF-I transcription pattern and the respective products may possess different functions. Inparticular, IGF-IEc was found to be involved in several conditions and pathologies, such as skeletal and cardiac muscle damage and regeneration, endometriosis, osteosarcoma, prostate cancer, etc. The role of IGF-IEc isoform in the aforementioned conditions still eludes our grasp, nevertheless there is evidence that the Ec peptide of this IGF-I isoform may act via an IGF-I receptor (IGF-IR)- independent and insulin receptor (IR)-independent pathway, thus potentially via an, as yet, unknown receptor molecule. Herein, we describe the experimental design for the isolation of the possible receptor of the Ec peptide of the IGF-IEc isoform with the use of an affinity purification assay."],"dc:identifier":["uoadl:1314817","https://pergamos.lib.uoa.gr/uoa/dl/object/1314817"],"dc:language":["English"],"dc:title":["Experimental design for the isolation of the possible receptor of the peptide Ec of the IGF-1Ec isoform with an affinity purification assay"],"dc:type":["born_digital_postgraduate_thesis","Διπλωματική Εργασία","Postgraduate Thesis"]},"updated_at":"2026-11-19T05:23:55Z"}